- Home
- Publications
- Publication Search
- Publication Details
Title
Deregulation of the miR-16-KRAS axis promotes colorectal cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-18
DOI
10.1038/srep37459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer
- (2016) Sheema Sameen et al. JOURNAL OF THEORETICAL BIOLOGY
- miR-16 promotes the apoptosis of human cancer cells by targeting FEAT
- (2015) Hongwei Liang et al. BMC CANCER
- miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells
- (2015) Hantao Wang et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity
- (2015) Pedro Queirós et al. VIRCHOWS ARCHIV
- MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer
- (2015) Chang-feng Li et al. OncoTargets and Therapy
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
- (2014) Aristea Kalikaki et al. PLoS One
- Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells
- (2013) Yang Ke et al. FEBS LETTERS
- KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
- (2012) Jasmina-Ziva Cerne et al. BMC CANCER
- Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung Cancer
- (2012) Raffaele Califano et al. DRUGS
- MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
- (2012) Long R. Jiao et al. PLoS One
- KRAS and BRAF: drug targets and predictive biomarkers
- (2010) Efsevia Vakiani et al. JOURNAL OF PATHOLOGY
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS
- (2010) Matthias Lauth et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1 and -2 in Colon Cancer
- (2009) H. Kikuchi et al. CANCER RESEARCH
- miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
- (2009) R I Aqeilan et al. CELL DEATH AND DIFFERENTIATION
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started